Anemia significantly impacts global public health, with over 571 million women at risk of adverse health outcomes due to iron deficiency and other causes.
AnaptysBio touts PhIII win in a rare form of psoriasis. But it doesn’t plan on keeping the drug
AnaptysBio’s antibody for a rare form of psoriasis passed a Phase III study, but it’s still getting the boot, the company announced on Monday. After